首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS
【24h】

Chiral separation and quantification of R/S-amphetamine, R/S-methamphetamine, R/S-MDA, R/S-MDMA, and R/S-MDEA in whole blood by GC-EI-MS

机译:GC-EI-MS对全血中R / S-苯异丙胺,R / S-甲基苯丙胺,R / S-MDA,R / S-MDMA和R / S-MDEA进行手性分离和定量

获取原文
获取原文并翻译 | 示例
       

摘要

The enantioselective composition of the amphetamines is of interest, as the enantiomers show differences in their pharmacological effects and several methods for chiral separation of amphetamines have been described. Only a few methods have used whole blood as matrix and none of these separates both classic amphetamines (amphetamine and methamphetamine) and designer amphetamines (MDA, MDMA and MDEA). The aim of this study was, therefore, to develop a method for enantioselective analysis of AM, MA, MDA, MDMA, and MDEA in whole blood. The amphetamines were extracted from 0.5 g of whole blood by liquid-liquid extraction. After derivatization with R-MTPCl, the resulting diastereomers were separated by GC on a HP-5MS column and detected by SIM-MS. R-MTPCl was used as derivatization reagent because of the stability of this reagent and good separation of these analytes. Through the method, development time and temperature of the derivatization were optimized, and by admixture of 0.02% triethylamine it became possible to detect the amphetamines in adequately low concentrations as more analytes were derivatized. The method was validated and it was linear from 0.004 to 3 mu g/g per enantiomer. The accuracy was within 91-115%, while the repeatability and reproducibility were <= 15% R.S.D. A method suitable for enantioselective separation and analysis of the amphetamines has been achieved, and the method was applied to analysis of whole blood samples originating from traffic and criminal cases and post mortem cases. (c) 2006 Elsevier B.V. All rights reserved.
机译:苯丙胺的对映选择性组成是令人感兴趣的,因为对映异构体在其药理作用方面显示出差异,并且已经描述了几种用于苯丙胺的手性分离的方法。只有少数几种方法将全血用作基质,但没有一种方法能够分离经典的苯丙胺(苯丙胺和甲基苯丙胺)和专门的苯丙胺(MDA,MDMA和MDEA)。因此,本研究的目的是开发一种全血中AM,MA,MDA,MDMA和MDEA的对映选择性分析方法。通过液-液提取从0.5g全血中提取苯丙胺。用R-MTPC1衍生后,通过HP-5MS柱上的GC分离所得非对映异构体,并通过SIM-MS检测。 R-MTPC1用作衍生化试剂是因为该试剂的稳定性和这些分析物的良好分离。通过该方法,优化了衍生化反应的开发时间和温度,并且通过混合0.02%三乙胺,可以随着更多分析物的衍生化而以足够低的浓度检测苯丙胺。该方法经过验证,每个对映体线性为0.004至3μg/ g。准确度在91-115%之内,而重复性和重现性<= 15%R.S.D.已经建立了一种适用于苯丙胺的对映选择性分离和分析的方法,并将该方法用于交通,刑事案件和验尸案件中的全血样品分析。 (c)2006 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号